Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

3069315-48-3Salcaprozate Diacid Impurity

● In Stock

Catalogue No.:	VE0027009
CAS No.:	3069315-48-3
Mol. Formula:	C23H35NO6
Mol. Weight:	421.53 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 3069315-48-3

Parent drug

Salcaprozate

IUPAC Name

8-(2-(7-carboxyheptylcarbamoyl)phenoxy) octanoic acid

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

O=C(O)CCCCCCCOC1=CC=CC=C1C(NCCCCCCCC(O)=O)=O

InChI

InChI=1S/C23H35NO6/c25-21(26)15-7-3-1-5-11-17-24-23(29)19-13-9-10-14-20(19)30-18-12-6-2-4-8-16-22(27)28/h9-10,13-14H,1-8,11-12,15-18H2,(H,24,29)(H,25,26)(H,27,28)

Description

Salcaprozate Diacid Impurity (CAS 3069315-48-3) is a low-level process-related contaminant encountered during synthesis and purification of salcaprozate derivatives. This impurity poses analytical and quality control challenges due to its structural similarity to the parent diacid, requiring selective chromatographic separation and sensitive mass spectrometric detection. Characterization typically employs HPLC with validated gradient methods, LC-MS for molecular confirmation and NMR for structural assignment. Control strategies include optimized reaction stoichiometry, targeted crystallization and preparative chromatography to reduce carryover below specification limits consistent with ICH Q3A/Q3B principles. Stability profiling and routine impurity monitoring are recommended to mitigate safety and regulatory risks.